Purpose Acupuncture is a complementary and alternative medicine (CAM) modality that shows promise as a component of supportive breast cancer care. Lack of robust recruitment for clinical trial entry has limited the evidence base for acupuncture as a treatment modality among breast cancer survivors. The objective of this study is to identify key decision-making factors among breast cancer survivors considering entry into an acupuncture clinical trial for treatment of symptoms.
Introduction
Complementary and alternative medicine (CAM) use among cancer patients is common [1] [2] [3] [4] [5] . The 2007 National Health Interview Survey reports that 43.3 % of US cancer survivors used CAM in the last year, while 66.5 % reported ever using CAM [1] . There is an emerging evidence base for the use of CAM including the use of acupuncture [6] . However, relatively few CAM modalities used in supportive cancer care have been systematically tested for clinical efficacy [7] . Thus, there is an urgent need for rigorously designed and conducted randomized controlled trials (RCTs) of CAM interventions for cancer patients and survivors to establish the safety and efficacy of these interventions.
Acupuncture is a CAM modality that shows promise as a component of supportive cancer care [8] . In a survey study, close to half of breast cancer survivors want acupuncture to be offered in a comprehensive cancer center [5] . In a review of the National Cancer Institute-designated comprehensive cancer center Websites, 60 % of them mentioned acupuncture as a modality to be used for supportive cancer care [9] . To guide evidence-based integration of acupuncture into cancer care, more rigorous RCTs for specific clinical indications (e.g., pain, hot flashes, and fatigue) are needed. While effective recruitment is a critical step to the successful completion of these trials, evidence among cancer trials overall suggests that only a small percentage of cancer patients (3 %) participate in clinical trials in any given year [10] and many clinical trials fail in patient accrual [11] [12] [13] [14] . Furthermore, recruitment of minority patients in cancer clinical trials is lower than the general population [15] [16] [17] , a factor that limits our knowledge base with regard to disparities in cancer outcomes [18] .
It is not known what factors breast cancer survivors consider in choosing to participate in RCTs of acupuncture for symptom management. Although some factors may reflect general barriers to participation in cancer related clinical trials, others may be specific to symptom management for cancer survivors or to the use of CAM modalities such as acupuncture. Incorporating the patients' perspective into the design of RCTs for acupuncture could inform study designs and facilitate recruitment efforts, thus increasing the probability of completing successful and definitive trials that produce reliable data. The objective of this study is to identify attributes that influenced AfricanAmerican and Caucasian breast cancer survivors' willingness to participate in clinical trials of acupuncture for hot flashes, a very common symptom affecting this population [19] .
Methods
We conducted 25 open-ended, semistructured interviews with breast cancer survivors. Key inclusion criteria included women with stages I-III breast cancer who had finished primary cancer treatments and were experiencing daily hot flashes. Exclusion criteria were stage IV breast cancer and those who did not speak English. Participants were recruited from an urban academic cancer center. We used a heterogeneous purposeful sampling approach to ensure that the sample reflected a diversity of age, race, and social economic status. The population of patients in our cancer center were predominantly non-Hispanic African-American and non-Hispanic Caucasian and the sampling reflected this distribution of race and ethnicity. Regulatory approval was obtained through the University of Pennsylvania's Institutional Review Board as well as the Abramson Canter Center's Clinical Trial Scientific Review and Monitoring Committee. Informed consent was performed and obtained from each participant.
The interview questions were pilot tested among interviewers with role playing and refined following the initial five interviews to increase clarity. Interviewers were trained in semistructured interviewing techniques by a medical anthropologist (FB). Each interview lasted approximately one hour and was recorded and transcribed by a professional transcription company. Sociodemographic patient characteristics were collected at baseline. Interviewees were asked about their experience with hot flashes, attitudes about acupuncture use as a treatment modality, and their perspectives regarding participation in clinical trials of acupuncture that differ in design regarding the choice of the control intervention. The current report focuses on attitudes towards participating in a clinical trial. General information regarding the purpose and procedures of a randomized clinical trial (RCT) were provided in the introduction to this aspect of the interview. Interviewees were asked to indicate which of the following hypothetical study designs they would be most likely (or not) to participate and why: (1) acupuncture versus placebo acupuncture; (2) acupuncture versus medication; or (3) acupuncture versus standard care. Placebo acupuncture was described as a procedure that used needles that did not penetrate the skin and that are on different points of the body compared with standard acupuncture.
De-identified transcripts were imported into QSR NVivo 8.0 (QSR International Pty Ltd, Doncaster Victoria, Australia). Based on close reading of the transcripts, a coding scheme and coding dictionary were developed by the research team. Team members coded 5 transcripts together and the remaining transcripts were coded by two coders. Coding agreement was evaluated and discrepancies in codes discussed weekly in team meetings. We achieved saturation on all major themes after 25 interviews. A qualitative health research expert (EM) analyzed the data for recurring themes and significant thematic links. Statements and emerging themes were compared between transcripts of African-American and Caucasian women to identify potential thematic differences between these populations.
Results
The study participants included 13 Caucasian (52 %) and 12 African-American (48 %) women. The median age for participants was 57 years (with a range of 38-79 years). Fifteen (60 %) of the study participants had a college degree or greater, while 10 (40 %) did not complete college. Eleven (44 %) women reported entering menopause naturally, while medically induced menopause (defined as menopause brought on by surgical or medical processes) was identified in 13 (52 %) of the women. Fifteen of the participants (60 %) had used some form of CAM in the past 12 months. Four participants (16 %) had used acupuncture in the past (Table 1) .
Six major themes emerged from analysis of the data, each found to influence decision-making and some are conceptually linked ( Fig. 1): (1) symptom appraisal, (2) practical barriers, (3) beliefs and attitudes about interventions, (4) attitude toward RCTs, (5) trust, and (6) altruism. Below, we summarize these themes as they emerged in the data. Illustrative quotations are provided in the text and table (Table 2 ). Based upon the identified themes, attributes identified as key factors in decision making were identified (Table 3) .
Symptom appraisal Most of the women in this study expressed a willingness to participate in a trial if they were experiencing symptoms that significantly diminished their quality of life. The mere presence of symptoms (in this case, hot flashes) was not sufficient motivation for participation, given the time and effort required. Women weighed the pros and cons of participation, with the severity of symptoms balanced against the time and effort of participating in a study. When the anticipated decrease in symptom severity was great perceived to outweigh the perceived costs, women would express a willingness to participate as suggested in the quotation below.
I feel that if the hot flashes did get unbearable that I would automatically want to try the acupuncture and the medication. (#012; AA)
Practical barriers Perceived time, scheduling, travel, parking, and other logistical challenges were major barriers to willingness to participate in clinical trials; the women in this study were cautious about over-committing and introducing additional stress into their lives. The active stage of life of many breast cancer survivors is illustrated in the following statement.
I have three small children. My oldest is five. … Three and 18 months. So anytime that I need to leave the house … I need to rely on grandparents. (#007; C) Women who have demanding work schedules, are caring for young children or other family members, or who live a considerable distance from the treatment site often expressed Women with polypharmacy concerns or negative attitudes toward pharmacological interventions conveyed a general willingness to participate in an acupuncture trial, but reluctant 
Weighs Against Weighs Toward
Each attribute can be weighed on a spectrum that reflects the degree to which personal preferences make that attribute a factor that weighs the decision either against or towards willingness to participate in a clinical trial. The data from this study suggests that the first two attributes are especially salient in this decision making process These quotations are in addition to those presented within the text of the manuscript AA African American, C Caucasian to participate in a trial with a medication arm. Some were eager to avoid medications on the grounds that they were already taking too many pharmaceuticals.
I am on so much medication now that if I had a way of doing something that wouldn't be an additional pill bottle that I would have to worry about, contraindications … I would probably do acupuncture if it was available. (#017; AA)
These women were very open to the concept of exploring acupuncture as a non-pharmacological intervention for their symptoms.
Because I think as a cancer person, who has had cancer and has been treated with very invasive means, surgery, chemotherapy, radiation, you don't want another foreign object in your body. (#020; C) Attitude toward randomized clinical trials A desire to retain control of treatment decisions was stated as a reason for not participating in a RCT. Women were asked to respond to three possible study designs: acupuncture versus placebo acupuncture, acupuncture versus medication, and acupuncture versus standard care. Although the value of a comparison group in a study design was generally acknowledged, statements indicated a lack of understanding regarding the importance and process of random assignment to treatment groups. In some cases, respondents believed that they could choose between treatment arms with this belief persisting after explanation of the randomization process. Some respondents perceived randomizing to real versus placebo acupuncture as a "trick" and were concerned that women blinded to the treatment assignment would not know whether to expect a benefit from the intervention. Some conveyed a preference for two active treatment groups (rather than a placebo acupuncture group as a control) because all participants could then expect relief of symptoms. In general, women that did not understand the purpose or procedure of randomization were less willing to participate.
Trust The presence of trust mitigated reservations about the nature of RCTs. Trust in the provider and/or research team facilitated willingness to participate in any clinical trial, regardless of the study design. In some cases, women expressed a profound and comprehensive trust in the provider and research team.
If it was recommended by [name of institution] or in a trial or something, I would be more likely to trust that and then it would be okay. (#017; AA) These women were willing to participate in any clinical trial the provider recommended with few questions and expressed trust that the provider would ensure their safety regardless of the study design.
Altruism The presence of altruism was associated with openness to randomization as a participant in a RCT (to receiving placebo, medication, or acupuncture as necessitated by the study design without a choice regarding to which group they would be assigned). Expressions of altruism were closely associated with attitudes toward RCTs.
I would definitely want to participate [in a trial] because I think I would want to give back to all the women who have gone through trials before and have helped me to be able to have a doctor who can make decisions now based on findings. (#017; AA)
An understanding of the importance of blinding and randomization coupled with the belief that the scientific study of clinical care makes a significant contribution to society were meaningful motivators for participating in a clinical trial.
Attributes of decision making for participation in acupuncture RCTs
Informed by the emergent themes discussed above, six attributes of RCTs were identified as salient to decisions regarding willingness to participate ( Table 3 ). The importance of each attribute and the degree to which it weighs for or against participation is anticipated to vary across decision makers. For example, logistic challenges such as travel and time might weigh against participation for women with resource constraints but towards participation for a woman who lives close to the treatment facility and/or has adequate financial resources. We also note interactions among certain attributes as described above. For example, beliefs and attitudes about polypharmacy may influence willingness to participate in a clinical trial that includes a medication arm. In addition, altruism was associated with willingness to participate in a design with random assignment of a treatment arm. Consideration of these attributes can support the decision making process for women considering entry into an acupuncture clinical trial.
Comparison between African-American and Caucasian participants While the six major themes applied to both African-American and Caucasian participants, the two groups differed in how they weighed some of these factors. Compared with Caucasian participants, African-American participants heavily weighed the opinions of family members and friends when considering entry in an RCT. Caucasian participants were more likely to cite key information sources as the physician, other health professionals, the Internet, or past research participants. While some Caucasians did consult with family members, they stressed the importance of consulting health professionals because of clinicians' expertise in clinical trials. African-American participants consulted their physicians as well, but did not emphasize trust in physicians over family members solely due to the physicians' additional medical expertise.
African-American and Caucasian groups also differed in their perception of the placebo effect. While both groups expressed altruism as a motivating reason to participate in clinical trials, several African-American participants mentioned their dislike for placebos. The primary concern was regarding effectiveness. Some African-American participants were wary that their condition might worsen after they finished the study if they were a part of the placebo group. To these participants, it was acknowledged that the placebo may work during the study, but concern remained that the placebo arm would leave them without lasting benefits when the study ended. This barrier towards participation was not mentioned by the Caucasian participants.
Discussion
Acupuncture holds promise as a component of integrative oncology, but rigorous RCTs for specific clinical outcomes (e.g., pain and hot flashes) need to be tested in cancer populations to establish both safety and efficacy, and ultimately guide clinical care. In this study, we identified six patient-level factors that are weighed by breast cancer survivors when considering participation in an acupuncture RCT.
A key attribute of decisions regarding clinical trial entry for these participants was the severity of symptoms experienced. In a previous work, we have reported that the severity of hot flashes among breast cancer survivors is a key factor when considering acupuncture as a treatment modality [20] . We now report that symptom severity is also an important factor in willingness to participate in a clinical trial. Hot flashes are a common and bothersome clinical problem that affects almost two thirds of breast cancer survivors who experience greater frequency, duration, and severity of hot flashes than women who do not have breast cancer [19] [20] [21] [22] . In our sample, almost about half of women experienced natural menopause and half had surgical/ chemo induced menopause. Despite such distinctions, most women discussed their current experience of hot flashes within the bigger context of breast cancer survivorship. For example, some women felt when they went through natural menopause, they were prescribed hormone replacement therapy; however, with a breast cancer diagnosis, hormone therapy was stopped and their hot flashes became very bothersome and intrusive. Even if they did not interpret hot flash as a side effect of treatment, they attributed their current hot flash experience to the diagnosis of breast cancer. Furthermore, women appraised their hot flashes in the context of other competing and concurrent symptoms such as pain [20] . In summary, only if hot flashes were severe enough to have an impact on daily lives did women consider entry into a clinical trial.
Self-interest has been previously identified as an important factor in motivating cancer patients to participate in clinical trials [23] . Women weighed the severity of hot flashes against concerns about logistical considerations of participation. Practical issues such as time and transportation carried considerable weight in the decision making process. Women who felt that their schedules were already too full or who had significant concerns about commuting to and from a treatment site expressed unwillingness to participate in a trial. Previous studies have found that female cancer survivors cite being "too busy" as a major reason for declining to participate in trials [24] . Addressing the practical barriers to participation (e.g., offering free parking, setting up satellite sites to reduce the commute, and minimizing scheduling requirements) is important as part of a strategy to encourage participation in clinical trials. Although logistic issues are cited as barriers to clinical trial participation in general, they may be more prominent in trials that address symptom management in contrast to disease control. Many CAM interventions such as acupuncture or yoga involve weekly and occasional twice weekly treatments so the time/travel commitment for trial participants may be greater than conventional medication intervention trials. Furthermore, women perceive many options for the symptom treatment which may limit their willingness to address logistic barriers faced to participate in acupuncture clinical trials [25] .
Attitudes toward and knowledge about treatment modalities were significant factors influencing willingness to participate in specific trial designs. Women who wanted to avoid additional medications because of concerns about polypharmacy and medication side effects expressed an openness to acupuncture. Those who had heard positive stories about acupuncture, or who had experienced it themselves, were more willing to participate in a study of acupuncture to treat hot flashes. Similarly, Schneider et al. [25] found that those with prior experiences with CAM modalities were more likely to express willingness to participate in CAM trials. We report that women who were acupuncture naïve and/or had a fear of needles displayed an unwillingness to participate in an acupuncture trial. Some respondents expressed skepticism about the effectiveness of acupuncture. Several participants believed that skin puncture was contraindicated after their cancer treatment. Our findings suggest that efforts to recruit women to acupuncture clinical trials should include an intervention to increase participants' familiarity with the procedure. For example, audiovisual materials and patient testimonials that describe the experience of undergoing acupuncture treatments may increase familiarity with acupuncture and openness to trial entry.
Scientific literacy with respect to understanding components of study design was associated with greater expressed willingness to participate in a clinical trial. For some women, a negative attitude toward randomization and/or blinding presented a significant barrier to entry in a clinical trial. Several women discussed their aversion to receiving placebo because they would be "getting nothing" in return for their time and effort. Similarly, Ellis [23] and Madsen et al. [26] report that uneasiness with randomization along with the possibility of receiving placebo is significant barriers to participation in RCTs. Concerns about recurrence of symptoms following the end of the intervention (especially among placebo arms) and lack of consideration of patient preference in treatment assignment, are factors to consider in future designs of acupuncture RCTs. We report a range of expectations regarding the use of placebo acupuncture. Some indicate an expectation of initial placebo benefit but express concern that the placebo benefit would not be sustained. Our findings are consistent with a framework developed by Bishop et al. [27] , regarding ways in which people conceptualize sham acupuncture; as fake treatments, as not real acupuncture, as having real effects mediated by psychological mechanisms, and as being necessary for research. The investigation of attitudes towards sham acupuncture poses a particular challenge for researchers as expectations for efficacy of sham acupuncture vary significantly and the interaction between expectations and outcomes in clinical trials complicates inferences of clinical effectiveness [27, 28] . Limited understanding of principles of equipoise and the reasons for random assignment of treatment in clinical trials has also been reported in the lay public [29] . Interventions to increase scientific literacy with regard to clinical study design may decrease barriers to robust recruitment for RCTs.
Our findings suggest that altruism facilitates willingness to participate in RCTs. Trust in the provider and research team also influenced willingness to participate; when present trust was found to mitigate concerns about randomization, blinding, the use of a placebo, and the nature of the intervention. These findings are consistent with previous work regarding conventional medical therapy where a lack of trust and/or confidence in physicians and the medical community is found to be a barrier to study recruitment [23, 26] . Previous studies also report that some participants consider placebos to be a necessary component of research in the context of acupuncture clinical trials [27] .
The factors we found to influence decision making among African-Americans regarding clinical trial entry were generally consistent with previous studies. In particular, the importance of consulting with close family members was consistent with the recognized role of familial support during cancer treatment [30, 31] . Among African-American patients who declined participation in one study, 83 % of their family and friends had expressed similar reservations towards clinical trials [32] . We are the first to report reluctance towards taking placebos because of a temporary effect. While past studies have examined African-American's mistrust and misunderstandings towards the clinical trial process particularly in the context of the Tuskegee case [33] [34] [35] , they have not reported a negative attitude toward placebo due to its potential temporary effectiveness.
Our study has several limitations. First, our sample of participants was drawn from an urban tertiary medical center. Although this purposeful sampling approach was appropriate to generate a range of themes, future quantitative studies are needed to determine the prevalence and representativeness of our findings. Second, we asked questions regarding hypothetical participation in acupuncture trials rather than actual participation so the decision making attributes identified may not fully capture the complexity of a clinical decision related to trial participation. Finally, we explored the decision to enter an acupuncture clinical trial for the treatment of hot flashes among breast cancer survivors. Our findings may differ from other important CAM modalities such as yoga or the use of herbs as the nature of the interventions differ. However, these modalities share some attributes as well such as providing an alternative approach to traditional medicine.
In conclusion, we report findings that could contribute towards building a theoretical framework of decision making for breast cancer survivors considering entry into a CAM clinical trial. Our study identifies attributes that women consider and balance in this decision making process. Cancer survivors are a unique population. Theoretically based, tailored efforts to support informed decision making and robust clinical trial recruitment are needed to build the evidence base for CAM as a symptom treatment modality option for cancer survivors.
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